Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cognitive Development During Adulthood

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...

Alzheimer Disease l: Introduction

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...

Dementia l: Introduction

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...

Language and Cognition

Language and Cognition

Language serves as a bridge between ideas and communication, influencing how individuals perceive and interact with the world. Psychologists have long debated whether language shapes thought or vice versa. This discussion gained grip with Edward Sapir and Benjamin Lee Whorf in the 1940s, who proposed that language determines thought, a concept known as linguistic determinism. They suggested that the vocabulary and structure of a language influence how its speakers think and perceive reality.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Genome-wide association study identifies four novel loci associated with Alzheimer's endophenotypes and disease modifiers.

Acta neuropathologica·2017

Same author

Tau aggregation influences cognition and hippocampal atrophy in the absence of beta-amyloid: a clinico-imaging-pathological study of primary age-related tauopathy (PART).

Acta neuropathologica·2017

Same author

Tau-PET uptake: Regional variation in average SUVR and impact of amyloid deposition.

Alzheimer's & dementia (Amsterdam, Netherlands)·2017

Same author

Association Between Mentally Stimulating Activities in Late Life and the Outcome of Incident Mild Cognitive Impairment, With an Analysis of the APOE ε4 Genotype.

JAMA neurology·2017

Same author

Duration and Pathologic Correlates of Lewy Body Disease.

JAMA neurology·2017

Same author

<i>ABCA7</i> loss-of-function variants, expression, and neurologic disease risk.

Neurology. Genetics·2017

Search research articles

Related Experiment Video

Updated: Jul 17, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

Mild cognitive impairment: current research and clinical implications.

Ronald C Petersen¹

¹Alzheimer's Disease Research Center, Department of Neurology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA.

Seminars in Neurology

|January 18, 2007

Summary

Mild cognitive impairment (MCI) is a stage between normal aging and dementia. Research explores MCI predictors, outcomes, and clinical trial results to guide future dementia research and practice.

More Related Videos

Transcranial Direct Current Stimulation (tDCS) for Memory Enhancement

Transcranial Direct Current Stimulation (tDCS) for Memory Enhancement

Published on: September 18, 2021

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing

Published on: January 24, 2020

Related Experiment Videos

Last Updated: Jul 17, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

Transcranial Direct Current Stimulation (tDCS) for Memory Enhancement

Transcranial Direct Current Stimulation (tDCS) for Memory Enhancement

Published on: September 18, 2021

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing

Published on: January 24, 2020

Area of Science:

Neurology
Gerontology
Cognitive Science

Background:

Mild cognitive impairment (MCI) represents a transitional phase between normal aging and dementia.
MCI has garnered significant research interest due to its clinical implications and potential as an early indicator of neurodegenerative disease.

Purpose of the Study:

To present clinical guidelines for mild cognitive impairment (MCI).
To discuss the clinical outcomes and predictors of progression in individuals with MCI.
To review completed MCI clinical trials and propose future research directions.

Main Methods:

Review of existing literature on mild cognitive impairment (MCI) criteria and clinical guidelines.
Analysis of studies identifying predictors of MCI progression (genetic, neuroimaging, biomarkers, clinical characteristics).
Discussion of completed MCI clinical trials and their implications for future research.

Main Results:

Variability in MCI outcomes and progression predictors exists.
Controversies persist regarding the neuropathology underlying MCI.
Lessons learned from completed MCI trials offer insights for future investigations.

Conclusions:

Mild cognitive impairment (MCI) is a critical area for research and clinical practice.
Understanding MCI progression and predictors is key to early intervention strategies.
Future research should focus on refining diagnostic criteria and therapeutic approaches for MCI.